Niel M. Henriksen

Niel M. Henriksen

Auto-generated profile, based on publicly available information

Niel M. Henriksen

Atomwise Inc

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
ARAndrea Rizzi
Andrea Rizzi
TJTravis Jensen
Travis Jensen
DSDavid R. Slochower
David R. Slochower
MAMatteo Aldeghi
Matteo Aldeghi
VGVytautas Gapsys
Vytautas Gapsys
JCJohn Chodera
John Chodera

15 November 2017 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
KAKhaleel Ibrahim Assaf
Khaleel Ibrahim Assaf
MFMara Florea
Mara Florea
JAJens Antony
Jens Antony
NHNiel M. Henriksen
Niel M. Henriksen
JYJian Yin
Jian Yin
WNWerner M. Nau
Werner M. Nau

18 July 2019 in Journal of the American Chemical Society
Verified
Journal Article
Open access
CCCassandra E. Callmann
Cassandra E. Callmann
CLClare L. M. LeGuyader
Clare L. M. LeGuyader
SBSpencer T. Burton
Spencer T. Burton
MTMatthew P. Thompson
Matthew P. Thompson
RHRobert Hennis
Robert Hennis
NGNathan C. Gianneschi
Nathan C. Gianneschi
We describe the design, synthesis, and antitumor activity of an 18 carbon α,ω-dicarboxylic acid monoconjugated via an ester linkage to paclitaxel (PTX). This 1,18-octadecanedioic acid-PTX (ODDA-PTX) prodrug readily forms a noncovalent complex with human serum albumin (HSA). Preservation of the terminal carboxylic acid moiety on ODDA-PTX enables binding to HSA in the same manner as native long-chain fatty acids (LCFAs), within hydrophobic pockets, maintaining favorable electrostatic contacts between the ω-carboxylate of ODDA-PTX and positively charged amino acid residues of the protein. This carrier strategy for small molecule drugs is based on naturally evolved interactions between LCFAs and HSA, demonstrated here for PTX. ODDA-PTX shows differentiated pharmacokinetics, higher maximum tolerated doses and increased efficacy in vivo in multiple subcutaneous murine xenograft models of human cancer, as compared to two FDA-approved clinical formulations, Cremophor EL-formulated paclitaxel (crPTX) and Abraxane (nanoparticle albumin-bound (nab)-paclitaxel).

31 May 2017 in Journal of Chemical Theory and Computation
Verified
Journal Article
Open access
GHGermano Heinzelmann
Germano Heinzelmann
NHNiel M. Henriksen
Niel M. Henriksen
MGMichael K. Gilson
Michael K. Gilson
Bromodomains, protein domains involved in epigenetic regulation, are able to bind small molecules with high affinity. In the present study, we report free energy calculations for the binding of seven ligands to the first BRD4 bromodomain, using the attach-pull-release (APR) method to compute the reversible work of removing the ligands from the binding site and then allowing the protein to relax conformationally. We test three different water models, TIP3P, TIP4PEw, and SPC/E, as well as the GAFF and GAFF2 parameter sets for the ligands. Our simulations show that the apo crystal structure of BRD4 is only metastable, with a structural transition happening in the absence of the ligand typically after 20 ns of simulation. We compute the free energy change for this transition with a separate APR calculation on the free protein and include its contribution to the ligand binding free energies, which generally causes an underestimation of the affinities. By testing different water models and ligand parameters, we are also able to assess their influence in our results and determine which one produces the best agreement with the experimental data. Both free energies associated with the conformational change and ligand binding are affected by the choice of water model, with the two sets of ligand parameters affecting their binding free energies to a lesser degree. Across all six combinations of water model and ligand potential function, the Pearson correlation coefficients between calculated and experimental binding free energies range from 0.55 to 0.83, and the root-mean-square errors range from 1.4–3.2 kcal/mol. The current protocol also yields encouraging preliminary results when used to assess the relative stability of ligand poses generated by docking or other methods, as illustrated for two different ligands. Our method takes advantage of the high performance provided by graphics processing units and can readily be applied to other ligands as well as other protein systems.

11 July 2017 in Journal of Chemical Theory and Computation
Verified
Journal Article
Open access
NHNiel M. Henriksen
Niel M. Henriksen
MGMichael K. Gilson
Michael K. Gilson
Computational prediction of noncovalent binding free energies with methods based on molecular mechanical force fields has become increasingly routine in drug discovery projects, where they promise to speed the discovery of small molecule ligands to bind targeted proteins with high affinity. Because the reliability of free energy methods still has significant room for improvement, new force fields, or modifications of existing ones, are regularly introduced with the aim of improving the accuracy of molecular simulations. However, comparatively little work has been done to systematically assess how well force fields perform, particularly in relation to the calculation of binding affinities. Hardware advances have made these calculations feasible, but comprehensive force field assessments for protein–ligand sized systems still remain costly. Here, we turn to cyclodextrin host–guest systems, which feature many hallmarks of protein–ligand binding interactions but are generally much more tractable due to their small size. We present absolute binding free energy and enthalpy calculations, using the attach-pull-release (APR) approach, on a set of 43 cyclodextrin-guest pairs for which experimental ITC data are available. The test set comprises both α- and β-cyclodextrin hosts binding a series of small organic guests, each with one of three functional groups: ammonium, alcohol, or carboxylate. Four water models are considered (TIP3P, TIP4Pew, SPC/E, and OPC), along with two partial charge assignment procedures (RESP and AM1-BCC) and two cyclodextrin host force fields. The results suggest a complex set of considerations when choosing a force field for biomolecular simulations. For example, some force field combinations clearly outperform others at the binding enthalpy calculations but not for the binding free energy. Additionally, a force field combination which we expected to be the worst performer gave the most accurate binding free energies – but the least accurate binding enthalpies. The results have implications for the development of improved force fields, and we propose this test set, and potential future elaborations of it, as a powerful validation suite to evaluate new force fields and help guide future force field development.

6 June 2018 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
JYJian Yin
Jian Yin
NHNiel M. Henriksen
Niel M. Henriksen
HMHari S. Muddana
Hari S. Muddana
MGMichael K. Gilson
Michael K. Gilson